Gene · 90
Papers2,859
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 2,859
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comparative proteomic analysis identifies differentially expressed proteins and reveals potential mechanisms of traumatic heterotopic ossification progression. | J Orthop Translat | 2022 | 35615641 | PubTator, text mining | PubMed |
| Momelotinib for the treatment of myelofibrosis with anemia. | Future Oncol | 2022 | 35603634 | PubTator, text mining | PubMed |
| Characterization of Tumor Mutation Burden-Based Gene Signature and Molecular Subtypes to Assist Precision Treatment in Gastric Cancer. | Biomed Res Int | 2022 | 35601155 | PubTator, text mining | PubMed |
| Therapeutic Targeting the Allosteric Cysteinome of RAS and Kinase Families. | J Mol Biol | 2022 | 35595166 | PubTator, text mining | PubMed |
| Recurrent ACVR1 mutations in posterior fossa ependymoma. | Acta Neuropathol | 2022 | 35587280 | PubTator, text mining | PubMed |
| Functionalized Macrophage Exosomes with Panobinostat and PPM1D-siRNA for Diffuse Intrinsic Pontine Gliomas Therapy. | Adv Sci (Weinh) | 2022 | 35585670 | PubTator, text mining | PubMed |
| Exploring the Genetic Architecture of Spontaneous Coronary Artery Dissection Using Whole-Genome Sequencing. | Circ Genom Precis Med | 2022 | 35583931 | PubTator, text mining | PubMed |
| Relationship between impaired BMP signalling and clinical risk factors at early-stage vascular injury in the preterm infant. | Thorax | 2022 | 35580897 | PubTator, text mining | PubMed |
Prohaptoglobin inhibits the transforming growth factor-β-induced epithelial-to-mesenchymal transition in vitro by increasing Smad1/5 activation and suppressing the Smad2/3 signaling pathway in SK-Hep1 liver cancer cells. | PLoS One | 2022 | 35580109 | PubTator, text mining | PubMed |
| Inflammasomes and the IL-1 Family in Bone Homeostasis and Disease. | Curr Osteoporos Rep | 2022 | 35567665 | PubTator, text mining | PubMed |
| Promising Chemotherapy for Malignant Pediatric Brain Tumor in Recent Biological Insights. | Molecules | 2022 | 35566032 | PubTator, text mining | PubMed |
| Long Non-Coding RNAs in Pancreatic Cancer: Biologic Functions, Mechanisms, and Clinical Significance. | Cancers (Basel) | 2022 | 35565245 | PubTator, text mining | PubMed |
| Inhibiting ALK2/ALK3 Signaling to Differentiate and Chemo-Sensitize Medulloblastoma. | Cancers (Basel) | 2022 | 35565225 | PubTator, text mining | PubMed |
| The Role Of BMPs in the Regulation of Osteoclasts Resorption and Bone Remodeling: From Experimental Models to Clinical Applications. | Front Immunol | 2022 | 35558080 | PubTator, text mining | PubMed |
| EZH2 engages TGFβ signaling to promote breast cancer bone metastasis via integrin β1-FAK activation. | Nat Commun | 2022 | 35538070 | PubTator, text mining | PubMed |
| Recent progress in drug development for fibrodysplasia ossificans progressiva. | Mol Cell Biochem | 2022 | 35536530 | PubTator, text mining | PubMed |
| Risk stratification of H3 K27M-mutant diffuse midline gliomas based on anatomical locations: an integrated systematic review of individual participant data. | J Neurosurg Pediatr | 2022 | 35535848 | PubTator, text mining | PubMed |
| LINC00922 promotes deterioration of gastric cancer. | PLoS One | 2022 | 35511773 | PubTator, text mining | PubMed |
| Targeting genome integrity dysfunctions impedes metastatic potency in non-small cell lung cancer circulating tumor cell-derived explants. | JCI Insight | 2022 | 35511434 | PubTator, text mining | PubMed |
| Anti-ACVR1 antibodies exacerbate heterotopic ossification in fibrodysplasia ossificans progressiva (FOP) by activating FOP-mutant ACVR1. | J Clin Invest | 2022 | 35511419 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/90/papers?page=32